STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration

Jing Chen, Mubiao Liu, Huawen Li et al.|Clinical & Translational Oncology|2022

Cited by 10